Importantly, we noted a positive correlation between bevacizumab‐induced blood vessel area downregulation in 3‐day organ‐cultured psoriasis plaques ex vivo with the VEGF‐A plasma levels of psoriasis patients (r = 0.94, *p < 0.05; Figure 4c). This evidence concerns the gene VEGFA and psoriasis.